JPJérémy Picard

Jérémy Picard

*This is an algorithmically generated author record based on publicly available information.

Jérémy Picard has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Antibiotic resistance of bacteria isolated from microbiological control of gastrointestinal endoscopes

    by Jérémy Picard, Nicolas Galakhoff, Hervé Le Bars, Christopher Payan, Elodie Moalic, Geneviève Héry-Arnaud, Raoul Baron, Julien Jézéquel, Philippe Saliou

  • Open Access

    Prevention of carbapenemase-producing Enterobacterales outbreaks: evaluation of a simplified contact screening policy

    by Jérémy Picard, Nicolas Galakhoff, Raoul Baron, Geneviève Héry-Arnaud, Clémence Beauruelle, Hervé Le Bars, Séverine Ansart, Gwenaël Cornec, Anne Coste, Aurore Trameçon, et al.

  • Open Access

    Is Metagenomics the Future Routine Diagnosis Tool for Brain Abscesses? About a Case

    by William Lars, Claudie Lamoureux, Jérémy Picard, Christophe Rodriguez, Clémence Beauruelle, Luc Quaesaet, Geneviève Héry-Arnaud, Séverine Ansart, Anne Coste

    Shotgun metagenomics (SMg) usefulness for brain abscess diagnosis is not known. We describe a case of brain abscess diagnosed with SMg and provide a review of the literature. A 70-year-old woman was diagnosed with multiple brain abscesses. Standard culture techniques and 16S rRNA gene sequencing of abscess samples remained negative. SMg finally revealed the presence of sequences from Streptococcus anginosus and Fusobacterium nucleatum, leading to antimicrobial treatment adaptation and corticosteroids initiation. The patient finally recovered. A literature review retrieved fifteen other cases of brain abscesses diagnosed with SMg. SMg results led to changes in patient management in most cases. The existing literature about the performances of SMg, its advantages, future evolutions, and limitations is then discussed. SMg place in routine should be evaluated and defined through prospective studies.


  • Comorbidities directly extracted from the hospital database for adjusting SSI risk in the new national semiautomated surveillance system in France: The SPICMI network

    by Jérémy Picard, Béatrice Nkoumazok, Isabelle Arnaud, Delphine Verjat-Trannoy, Pascal Astagneau

    Objective:To evaluate the performance of a comorbidity-based risk-adjustment model for surgical-site infection (SSI) reporting and benchmarking using a panel of variables extracted from the hospital discharge database (HDD), including comorbidities, compared to other models that use variables from different data sources.Methods:The French national surveillance program for SSI (SPICMI) has collected data from voluntary hospitals in the first 6 months of 2020 and 2021, for 16 selected surgery procedures, using a semiautomated algorithm for detection. Four risk-adjustment models were selected with logistic regression analysis, combining the different patterns of variables: National Nosocomial Infections Surveillance System (NNIS) risk-index components, individual operative data, and 6 individual comorbidities according to International Classification of Disease, Tenth Revision (ICD-10) diagnosis: obesity, diabetes, malnutrition, hypertension, cancer, or immunosuppression. Areas under the curve (AUCs) were calculated and compared.Results:Overall, 294 SSI were detected among 11,975 procedures included. All 6 comorbidities were related to SSI in the univariate analysis. The AUC of the selected model including comorbidities (0.675; 95% confidence interval [CI], 0.642–0.707), was significantly higher than the AUC of the model without comorbidities (0.641; 95% CI, 0.609–0.672; P = .016) or the AUC using the NNIS-index components (0.598; 95% CI, 0.564–0.630; P < .001). The HDD-based model AUC (0.659; 95% CI, 0.625–0.692) did not differ significantly from the selected model without comorbidities (P = .23).Conclusion:Including HDD-based comorbidities as patient case-mix variables instead of NNIS risk index factors could be an effective approach for risk-adjustment of automated SSI surveillance more widely accessible to hospitals.